Status:
UNKNOWN
Non Invasive Detection of Lung and Breast Cancer by Odor Signature
Lead Sponsor:
BioSense Medical LTD
Collaborating Sponsors:
Sheba Medical Center
Conditions:
Lung Cancer
Breast Cancer
Eligibility:
All Genders
30-80 years
Brief Summary
The investigators have developed an early detection solution for lung and breast cancer. A system which can distinguish between different medical odors based on biosensors. Our product is user-friendl...
Detailed Description
Early detection of cancer can dramatically improve the survival chances. to date, there is no efficient diagnostic tool for detection of lung cancer in early stages. Regarding breast cancer, the commo...
Eligibility Criteria
Inclusion
- Diagnosed Lung Cancer patients
- Diagnosed Breast Cancer patients
Exclusion
- Cancer patients who were treated using chemotherapy
- Cancer patients who were treated using radiation
- Cancer patients who were treated using biological treatments
- Cancer patients who were treated with chemotherapy
- Cancer patients who were treated with any anti- cancer therapies
- Cancer patients who use drugs that affect the immune system
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT02195076
Start Date
July 1 2014
Last Update
July 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba Medical Center
Tel Hashomer, Ramat- Gan, Israel, 52621